معرفی
Chrissie Jones is an Associate Professor in Paediatric Infection & Immunology at the University of Southampton, affiliated with the Faculty of Medicine and Department of Paediatrics and Child Health. She specializes in maternal and neonatal infectious disease prevention, with a focus on vaccination strategies during pregnancy and early childhood. Her research addresses congenital infections, CMV prevention, and maternal immunization efficacy.
Education and Qualifications:
- BMedSci, BMBS (Medical Degree)
- FRCPCH (Fellowship of the Royal College of Paediatrics and Child Health)
- PgcertHBE (Postgraduate Certificate in Healthcare Education)
- FHEA (Fellow of the Higher Education Academy)
- PhD (Doctorate in Medical Sciences)
Research Interests: Her work spans vaccination in pregnancy, CMV prevention, and maternal-fetal infection dynamics. She leads the IMPRINT global network for maternal-infant vaccination research and has pioneered behavioral interventions to reduce congenital CMV transmission. Her studies include clinical trials for RSV, pertussis, and CMV vaccines in pregnant populations.
Publications Trends: Recent work emphasizes maternal immunization efficacy, neonatal microbiome interactions, and global vaccine equity. Key studies include human challenge trials in pregnancy, microbiome toxicity analyses, and guideline development for HSV management in pregnancy.
Scientific Awards:
- Fellowship of Royal College of Paediatrics and Child Health (2020)
- Distinguished Award for Education (2022)
- Faculty of Medicine Dean's Award for Most Supportive PGR Supervisor (2023)
Advising and Grants: Supervises PhD students in infectious disease research and leads multiple projects funded by the Medical Research Council (MRC) and the Vaccine GRID Foundation. Serves as co-director of the IMPRINT network and chairs committees for the European Society for Paediatric Infectious Diseases.
Labs/Teams: Leads the Paediatric Infection Research Group at Southampton and collaborates with global networks like the European Congenital CMV Initiative. Active in clinical trials for maternal vaccines and post-COVID-19 pandemic responses.
